Andrew M. Blanks

Andrew M. Blanks

Auto-generated profile, based on publicly available information

Andrew M. Blanks

Affiliation Cell and Developmental Biology, Division of Biomedical Sciences Warwick Medical School, Coventry, United Kingdom

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2004 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
MTMarco van Den Top
Marco van Den Top
KLKevin Lee
Kevin Lee
AWAndrew D Whyment
Andrew D Whyment
ABAndrew M Blanks
Andrew M Blanks
DSDavid Spanswick
David Spanswick

9 January 2014 in Experimental Physiology
Verified
Journal Article
Open access
PDF file
YCYi‐Wah Chan
Yi‐Wah Chan
HBHugo A. van Den Berg
Hugo A. van Den Berg
JMJonathan D. Moore
Jonathan D. Moore
SQSiobhan Quenby
Siobhan Quenby
ABAndrew M. Blanks
Andrew M. Blanks
New Findings: What is the central question of this study? In this study, we sought to survey the total transcript repertoire of human myometrium, comparing samples taken from patients at term who were not in labour with samples taken at term in spontaneous labour. These sequenced transcriptomes show the repertoire of possible proteins and their variants in myometrial smooth muscle, as well as transcriptional changes associated with term spontaneous labour. What is the main finding and its importance? We describe, for the first time, the transcriptome of the human myometrial samples taken from patients prior to and after the onset of spontaneous labour. We document a significant number of novel transcripts of both protein‐coding mRNA and microRNA. This information will be useful for the development of novel therapeutics and the formulation of new hypotheses to be tested by physiological experimentation. The transition of the human uterus from a quiescent to a contractile state takes place over a number of weeks. On such biological time scales, cellular phenotype is modified by changes in the transcriptome, which in turn is under the control of the underlying endocrine, paracrine, and biophysical processes resulting from the ongoing pregnancy. In this study, we characterize the transition of the human myometrial transcriptome at term from not in labour (NIL) to in labour (LAB) using high throughput RNA sequencing (RNA‐seq). RNA was isolated from the myometrium of uterine biopsies from patients at term who were not in labour (n = 5) and at term in spontaneous labour (n = 5) without augmentation. A total of 143.6 million separate reads were sequenced, achieving, on average, ∼13 times coverage of the expressed human transcriptome per sample. Principal component analysis indicated that the NIL and LAB transcriptomes could be distinguished as two distinct clusters. A comparison of the NIL and LAB groups, using three different statistical approaches (baySeq, edgeR, and DESeq), demonstrated an overlap of 764 differentially expressed genes. A comparison with currently available microarray data revealed only a partial overlap in differentially expressed genes. We conclude that the described RNA‐seq data sets represent the first fully annotated catalogue of expressed mRNAs in human myometrium. When considered together, the full expression repertoire and the differentially expressed gene sets should provide an excellent resource for formulating new hypotheses of physiological function, as well as the discovery of novel therapeutic targets.

23 July 2014 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
CMConor McCloskey
Conor McCloskey
CRCara Rada
Cara Rada
EBElizabeth Bailey
Elizabeth Bailey
SMSamantha McCavera
Samantha McCavera
HBHugo A van Den Berg
Hugo A van Den Berg
ABAndrew M Blanks
Andrew M Blanks
Abnormal uterine activity in pregnancy causes a range of important clinical disorders, including preterm birth, dysfunctional labour and post‐partum haemorrhage. Uterine contractile patterns are controlled by the generation of complex electrical signals at the myometrial smooth muscle plasma membrane. To identify novel targets to treat conditions associated with uterine dysfunction, we undertook a genome‐wide screen of potassium channels that are enriched in myometrial smooth muscle. Computational modelling identified Kir7.1 as potentially important in regulating uterine excitability during pregnancy. We demonstrate Kir7.1 current hyper‐polarizes uterine myocytes and promotes quiescence during gestation. Labour is associated with a decline, but not loss, of Kir7.1 expression. Knockdown of Kir7.1 by lentiviral expression of miRNA was sufficient to increase uterine contractile force and duration significantly. Conversely, overexpression of Kir7.1 inhibited uterine contractility. Finally, we demonstrate that the Kir7.1 inhibitor VU590 as well as novel derivative compounds induces profound, long‐lasting contractions in mouse and human myometrium; the activity of these inhibitors exceeds that of other uterotonic drugs. We conclude Kir7.1 regulates the transition from quiescence to contractions in the pregnant uterus and may be a target for therapies to control uterine contractility. Synopsis Only few effective treatments can manipulate uterine contractility for the prevention of dystocia, preterm labor or post‐partum hemorrhage. This study reveals Kir7.1 channel as a potential target for increasing uterine contractions and identifies novel Kir7.1 inhibitors. A genome‐wide scan of all known potassium channels combined with computational modeling identified Kir7.1 as a potentially useful therapeutic target. Kir7.1 expression increases in mid gestation and declines towards the onset of labor in mice and humans. Kir7.1 inhibition in vitro and in vivo increases uterine contractility. Novel inhibitors of Kir7.1 induce contractions of greater magnitude than a commonly used uterine stimulant oxytocin.

6 September 2013 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
PDF file
RSRachel E. Sheldon
Rachel E. Sheldon
MBMarc Baghdadi
Marc Baghdadi
CMConor McCloskey
Conor McCloskey
ABAndrew M. Blanks
Andrew M. Blanks
ASAnatoly Shmygol
Anatoly Shmygol
HBHugo A. van Den Berg
Hugo A. van Den Berg
The muscular layer of the uterus (myometrium) undergoes profound changes in global excitability prior to parturition. Here, a mathematical model of the myocyte network is developed to investigate the hypothesis that spatial heterogeneity is essential to the transition from local to global excitation which the myometrium undergoes just prior to birth. Each myometrial smooth muscle cell is represented by an element with FitzHugh–Nagumo dynamics. The cells are coupled through resistors that represent gap junctions. Spatial heterogeneity is introduced by means of stochastic variation in coupling strengths, with parameters derived from physiological data. Numerical simulations indicate that even modest increases in the heterogeneity of the system can amplify the ability of locally applied stimuli to elicit global excitation. Moreover, in networks driven by a pacemaker cell, global oscillations of excitation are impeded in fully connected and strongly coupled networks. The ability of a locally stimulated cell or pacemaker cell to excite the network is shown to be strongly dependent on the local spatial correlation structure of the couplings. In summary, spatial heterogeneity is a key factor in enhancing and modulating global excitability.

1 October 2007 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
ABAndrew M. Blanks
Andrew M. Blanks
ASAnatoly Shmygol
Anatoly Shmygol
STSteven Thornton
Steven Thornton

1 July 2006 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
ASAnatoly Shmygol
Anatoly Shmygol
JGJoanna Gullam
Joanna Gullam
ABAndrew Blanks
Andrew Blanks
STSteven Thornton
Steven Thornton